Every year, more than 3,000 scientific abstracts are accepted for oral and poster presentation at the Society's annual meeting.
Urge Congress to find a balanced approach to deficit reduction that does not involve further cuts to biomedical research
Updated on: March 13, 2015
continues to work with Congress, federal agencies, and other stakeholders to
ensure continued access to safe and effective hematologic drugs.
FDA Reports Supply Issue with Cytarabine InjectionOn March 13, the FDA informed ASH of a potential supply
issue for cytarabine injection. The FDA
has not posted the shortage to their website because they are working closely
with the drug manufacturers to try and prevent supply impact. The American Society of Health-System
Pharmacists has posted details about the shortage on their website, which is
linked in the list below. If you have
any questions or concerns, please contact ASH or the FDA’s drug shortage office.
Blood: How I Treat Hematology 2013 ASH Academy ASH On Demand
September 17-19, 2015 Fairmont Chicago, Millennium ParkChicago, IL
ASH, the leading authority on malignant hematology, presents its newest clinical meeting.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology